Connect Biopharma Holdings Limited (CNTB) Return on equity 2023–2025
Connect Biopharma Holdings Limited (CNTB) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-132.2%FY2025 · since FY2023: -61.2% → -132.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -132.2% | -115.2 pp |
| FY2024 | -17.0% | +44.2 pp |
| FY2023 | -61.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More CNTB financial trends
CNTB RevenueCNTB Net incomeCNTB Net marginCNTB Gross profitCNTB Gross marginCNTB Operating incomeCNTB Operating marginCNTB Operating cash flowCNTB Free cash flowCNTB Capital expendituresCNTB Stock buybacksCNTB Dividends paidCNTB Total assetsCNTB Total liabilitiesCNTB Shareholders’ equityCNTB overview →